Stay updated on Favezelimab+Pembrolizumab in Hematologic Malignancies Clinical Trial

Sign up to get notified when there's something new on the Favezelimab+Pembrolizumab in Hematologic Malignancies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Favezelimab+Pembrolizumab in Hematologic Malignancies Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    Added a note that publications are automatically filled from PubMed and may not relate to the study; updated the page revision to v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-24T17:53:12.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The page no longer displays the government funding status notice that warned information may be out of date and directed users to operating-status pages. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-17T17:44:45.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Minor updates on the Study Details page, including the latest update timestamp and a new publication reference. No changes to study design, eligibility criteria, endpoints, or patient-facing information.
    Difference
    0.3%
    Check dated 2025-11-03T12:33:11.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    Summary: The page now displays a funding-status notice and an updated version tag (v3.2.0) while removing the old version tag (v3.1.0).
    Difference
    3%
    Check dated 2025-10-05T16:43:18.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    Page updated to version v3.1.0 and adds information about B-cell lymphoma; previous version tag v3.0.2 is removed.
    Difference
    0.1%
    Check dated 2025-09-28T09:52:12.000Z thumbnail image
  8. Check
    93 days ago
    Change Detected
    Summary
    Revision updated from v3.0.1 to v3.0.2, indicating a new release. Additionally, the 'Back to Top' element was removed as a minor UI cleanup.
    Difference
    0.2%
    Check dated 2025-09-14T00:12:20.000Z thumbnail image

Stay in the know with updates to Favezelimab+Pembrolizumab in Hematologic Malignancies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Favezelimab+Pembrolizumab in Hematologic Malignancies Clinical Trial page.